BHV-1 DNA vaccination: effect of the adjuvant RN-205 on the modulation of the immune response in mice.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Vaccine

• Publication date

  2002-06-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(02)00211-6PMID 12034090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression, purification, and characterization of the active immunoglobulin-like domain of human granulocyte-colony-stimulating factor receptor in Escherichia coli.

  2001cited by this paper
• Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.

  2000cited by this paper
• Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.

  2000cited by this paper
• DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).

  2000cited by this paper
• Altering the Cellular Location of an Antigen Expressed by a DNA-Based Vaccine Modulates the Immune Response

  1999cited by this paper
• Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1.

  1999cited by this paper
• BHV-1: New Molecular Approaches to Control a Common and Widespread Infection

  1999cited by this paper
• In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model

  1999cited by this paper
• Immunization of Neonates with DNA Encoding a Bovine Herpesvirus Glycoprotein Is Effective in the Presence of Maternal Antibodies*

  1999cited by this paper
• DNA/Genetic Vaccination (Minireview)

  1998cited by this paper
• Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle.

  1998cited by this paper
• Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.

  1998cited by this paper
• DNA vaccines.

  1998cited by this paper
• Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.

  1997cited by this paper
• Polynucleotide vaccines in animals: enhancing and modulating responses.

  1997cited by this paper
• The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs.

  1997cited by this paper
• Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection

  1996cited by this paper
• Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.

  1993cited by this paper
• The skin immune system: progress in cutaneous biology.

  1993cited by this paper
• Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity.

  1992cited by this paper
• Liposomes containing lipid A as a potent non-toxic adjuvant.

  1992cited by this paper
• Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.

  1991cited by this paper
• Lipopolysaccharide augments HLA-A,B,C molecule expression but inhibits interferon-gamma-induced HLA-DR molecule expression on cultured human endothelial cells.

  1991cited by this paper
• CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.

  1991cited by this paper
• Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.

  1991cited by this paper
• Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins.

  1990cited by this paper
• Infectious Bovine Rhinotracheitis / Vulvovaginitis (BHV1)

  1989cited by this paper
• Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells.

  1988cited by this paper
• Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins.

  1987cited by this paper
• Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

  1986cited by this paper
• Safety and efficacy of live and inactivated infectious bovine rhinotracheitis vaccines

  1982cited by this paper
• A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.

  1982cited by this paper
• A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.

  1982cited by this paper
• Evaluation of inactivated infectious bovine rhinotracheitis vaccines.

  1975cited by this paper
• EFFECT OF BACTERIA AND BACTERIAL PRODUCTS ON ANTIBODY RESPONSE.

  1964cited by this paper

• Galectin-8 and GEL01 as potential adjuvants to enhance the immune response induced by a DNA vaccine against bovine alphaherpesvirus Type-1.

  2025cites this paper
• Intranasal delivery of plasmids expressing bovine herpesvirus 1 gB/gC/gD proteins by polyethyleneimine magnetic beads activates long-term immune responses in mice

  2021cites this paper
• MANα1-2MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV-1.

  2020cites this paper
• Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity

  2019cites this paper
• Induction of Both Local Immune Response in Mice and Protection in a Rabbit Model by Intranasal Immunization with Modified Vaccinia Ankara Virus Expressing a Secreted Form of Bovine Herpesvirus 1 Glycoprotein D

  2017cites this paper
• In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes

  2014cites this paper
• Delivery of recombinant vaccines against bovine herpesvirus type 1 gD and Babesia bovis MSA-2c to mice using liposomes derived from egg yolk lipids.

  2013cites this paper
• Immunogenicity of a Bovine Herpes Virus I Peptide Expressed in Tandem Copies in Attenuated Salmonella

  2012cites this paper
• Evaluation of anti-Moraxella bovis pili immunoglobulin-A in tears following intranasal vaccination of cattle.

  2012cites this paper
• Recombinant MVA Expressing Secreted Glycoprotein D of BoHV-1 Induces Systemic and Mucosal Immunity in Animal Models

  2011cites this paper
• Bovine herpesvirus-1 vaccine's: a look from the past to the immunization future.

  2009cites this paper
• VACUNAS CONTRA EL HERPESVIRUS BOVINO-1: UNA MIRADA DESDE EL PASADO HACIA EL FUTURO DE LA INMUNIZACIÓN

  2009cites this paper
• Immune response to Neospora caninum in naturally infected heifers and heifers vaccinated with inactivated antigen during the second trimester of gestation.

  2005cites this paper
• Pseudorabies Virus Glycoprotein gD Contains a Functional Endocytosis Motif That Acts in Concert with an Endocytosis Motif in gB To Drive Internalization of Antibody-Antigen Complexes from the Surface of Infected Monocytes

  2005cites this paper
• Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity.

  2003cites this paper